Linvoseltamab
R5458-ONC-2246
Phase 3 small_molecule active
Quick answer
Linvoseltamab for Relapsed and/or Refractory Multiple Myeloma (RRMM) is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Relapsed and/or Refractory Multiple Myeloma (RRMM)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active